Search

Your search keyword '"Wada, Yuka Sano"' showing total 11 results
Start Over Author "Wada, Yuka Sano"
11 results on '"Wada, Yuka Sano"'

4. Mortality and morbidity of extremely low birth weight infants in Japan, 2015

Author

Miyazawa, Tokuo, primary, Arahori, Hitomi, additional, Ohnishi, Satoshi, additional, Shoji, Hromichi, additional, Matsumoto, Atsushi, additional, Wada, Yuka Sano, additional, Takahashi, Naoto, additional, Takayanagi, Toshimitsu, additional, Toishi, Satoshi, additional, Nagaya, Ken, additional, Hasegawa, Hisaya, additional, Hayakawa, Masahiro, additional, Hida, Mariko, additional, Fukuhara, Rie, additional, Yamada, Yasumasa, additional, Kawai, Masahiko, additional, Takashi, Kusaka, additional, Wada, Kazuko, additional, Morioka, Ichiro, additional, and Mizuno, Katsumi, additional

Published
2023
Full Text
View/download PDF

5. Transfer of Zolpidem to Cord Blood and Breast Milk: A Case Series Evaluating Zolpidem Serum Levels and Outcomes in Birth and Suckling Infants

Author

Saito, Jumpei, primary, Tachibana, Yoshiyuki, additional, Kawasaki, Hiroyo, additional, Tamon, Hiroki, additional, Ishii, Mariko, additional, Wada, Yuka Sano, additional, Oho, Motoko, additional, Yakuwa, Naho, additional, Suzuki, Tomo, additional, Sago, Haruhiko, additional, Yamatani, Akimasa, additional, and Murashima, Atsuko, additional

Published
2022
Full Text
View/download PDF

8. Remdesivir and Human Milk: A Case Study

Author

Wada, Yuka Sano, primary, Saito, Jumpei, additional, Hashii, Yuko, additional, Kishi, Tomomi, additional, Kobayashi, Masayuki, additional, Kamiya, Taro, additional, and Mizuno, Katsumi, additional

Published
2022
Full Text
View/download PDF

10. Long-term physical and neurodevelopmental outcomes after antenatal betamethasone administration for congenital heart block prevention.

Author

Wada, Yuka Sano, Hama, Ikuko, Goto, Mikako, Ito, Yushi, and Murashima, Atsuko

Abstract

Congenital heart block (CHB) is associated with a mortality rate of 20% and requires a pacemaker in 70% of cases. Steroids can reduce morbidity and prevent the onset of CHB but may have adverse effects on growth and neurodevelopment. This study aimed to clarify the long-term effects of antenatal betamethasone administration on growth and neurodevelopment. The subjects were children with a high risk of CHB due to a high level of maternal anti-SSA/Ro antibody or a maternal history of a previous delivery of a offspring with CHB to whom antenatal betamethasone was administered. Data on body weight, height, and blood pressure were collected as physical outcomes. The Wechsler Intelligence Scale for Children (fourth edition) or the Kyoto Scale of Psychological Development and the Pervasive Developmental Disorders Autism Society Japan Rating Scale was administered to assess the neurodevelopmental outcome. Fourteen children were enrolled. The body weight and height were within normal range in all children. All children had normal intelligence, and none had autism. Our study suggested that antenatal betamethasone administration has no negative effects on long-term physical and neurodevelopmental outcomes. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results